Search

Your search keyword '"Cerbarano, L"' showing total 4 results
Start Over Author "Cerbarano, L"
4 results on '"Cerbarano, L"'

1. Pisa syndrome in Parkinson disease

Author

Tinazzi, M, Fasano, A, Geroin, C, Morgante, F, Ceravolo, R, Rossi, S, Thomas, A, Fabbrini, G, Bentivoglio, A, Tamma, F, Cossu, G, Modugno, N., Zappia, M, Volonte, MA, Dallocchio, C, Abbruzzese, G, Pacchetti, C, Marconi, R, Defazio, G, Canesi, M, Cannas, A, Pisani, A, Mirandola, R, Barone, P, Vitale, C, Allocca, R, Altavilla, T, Bisoffi, G, Bombieri, F, Bove, F, Bovi, T, Cerbarano, L, Cordano, C, Di Giacomo, R, Di Stefano, F, Erro, R, Gallerini, S, Gandolfi, M, Gigante, AF, Juergenson, I, Lena, F, Leocani, LM, Lucchese, V, Madeo, G, Mazzucchi, S, Moccia, Marcello, Nicoletti, A, Ottaviani, S, Pezzoli, G, Pozzi, N, Ricciardi, L, Santangelo, G, Sarchioto, M, Schena, F, Sciaretta, M, Smania, N, Solla, P, Spagnolo, F, Ulivelli, M., Tinazzi, M, Fasano, A, Geroin, C, Morgante, F, Ceravolo, R, Rossi, S, Thomas, A, Fabbrini, G, Bentivoglio, A, Tamma, F, Cossu, G, Modugno, N., Zappia, M, Volonte, Ma, Dallocchio, C, Abbruzzese, G, Pacchetti, C, Marconi, R, Defazio, G, Canesi, M, Cannas, A, Pisani, A, Mirandola, R, Barone, P, Vitale, C, Allocca, R, Altavilla, T, Bisoffi, G, Bombieri, F, Bove, F, Bovi, T, Cerbarano, L, Cordano, C, Di Giacomo, R, Di Stefano, F, Erro, R, Gallerini, S, Gandolfi, M, Gigante, Af, Juergenson, I, Lena, F, Leocani, Lm, Lucchese, V, Madeo, G, Mazzucchi, S, Moccia, Marcello, Nicoletti, A, Ottaviani, S, Pezzoli, G, Pozzi, N, Ricciardi, L, Santangelo, G, Sarchioto, M, Schena, F, Sciaretta, M, Smania, N, Solla, P, Spagnolo, F, and Ulivelli, M.

Subjects
Cross-Sectional Studie, Levodopa, Male, Dystonia, Italy, Female, Parkinson Disease, Syndrome, Cohort Studie, Middle Aged, Aged, Dopamine Agonist, Human
Published
2015

2. Pisa syndrome in Parkinson disease

Author

Tinazzi, M., Fasano, A., Geroin, C., Morgante, F., Ceravolo, R., Rossi, S., Thomas, A., Fabbrini, G., Bentivoglio, A., Tamma, F., Cossu, G., Modugno, N., Zappia, M., Volontè, M. A., Dallocchio, C., Abbruzzese, G., Pacchetti, C., Marconi, R., Defazio, G., Canesi, M., Cannas, A., Pisani, A., Mirandola, R., Barone, P., Vitale, C., Italian Pisa Syndrome Study Group, Allocca, R., Altavilla, T., Bisoffi, G., Bombieri, F., Bove, F., Bovi, T., Cerbarano, L., Cordano, C., Di Giacomo, R., Di Stefano, F., Erro, R., Gallerini, S., Gandolfi, M., Gigante, A. F., Juergenson, I., Lena, F., Leocani, L. M., Lucchese, V., Madeo, G., Mazzucchi, S., Moccia, M., Nicoletti, A., Ottaviani, S., Pezzoli, G., Santangelo, G., Sarchioto, M., Schena, F., Sciarretta, M., Smania, N., Solla, P., Spagnolo, F., and Ulivelli, M.

Subjects
Male, Aged, Cohort Studies, Cross-Sectional Studies, Dopamine Agonists, Dystonia, Female, Humans, Italy, Levodopa, Middle Aged, Parkinson Disease, Syndrome, Neurology (clinical)
Published
2015

3. Pisa syndrome in Parkinson disease: An observational multicenter Italian study

Author

Tinazzi, Michele, Fasano, Alfonso, Geroin, Christian, Morgante, Francesca, Ceravolo, Roberto, Rossi, Simone, Thomas, Astrid, Fabbrini, Giovanni, Bentivoglio, Annarita, Tamma, Filippo, Cossu, Giovanni, Modugno, Nicola, Zappia, Mario, Volontè, Maria Antonietta, Dallocchio, Carlo, Abbruzzese, Giovanni, Pacchetti, Claudio, Marconi, Roberto, Defazio, Giovanni, Canesi, Margherita, Cannas, Antonino, Pisani, Antonio, Mirandola, Rina, Barone, Paolo, Vitale, Carmine, Allocca, R, Altavilla, T, Bisoffi, G, Bombieri, F, Bove, F, Bovi, T, Cerbarano, L, Cordano, C, Di Giacomo, R, Di Stefano, F, Erro, R, Gallerini, S, Gandolfi, M, Gigante, Af, Juergenson, I, Lena, F, Leocani, Lm, Lucchese, V, Madeo, G, Mazzucchi, S, Moccia, M, Nicoletti, A, Ottaviani, S, Pezzoli, G, Pozzi, N, Ricciardi, L, Santangelo, G, Sarchioto, M, Schena, F, Sciarretta, M, Smania, N, Solla, P, Spagnolo, F, Ulivelli, M., Tinazzi, Michele, Fasano, Alfonso, Geroin, Christian, Morgante, Francesca, Ceravolo, Roberto, Rossi, Simone, Thomas, Astrid, Fabbrini, Giovanni, Bentivoglio, Annarita, Tamma, Filippo, Cossu, Giovanni, Modugno, Nicola, Zappia, Mario, Volonte, Maria Antonietta, Dallocchio, Carlo, Abbruzzese, Giovanni, Pacchetti, Claudio, Marconi, Roberto, Defazio, Giovanni, Canesi, Margherita, Cannas, Antonino, Pisani, Antonio, Mirandola, Rina, Barone, Paolo, Vitale, Carmine, On behalf of the ItalianPisa Syndrome, Studygroup, and Leocani, L

Subjects
Camptocormia, Parkinson's Disease, Kyphosis, Male, medicine.medical_specialty, Levodopa, Movement disorders, Cross-sectional study, assessment, Logistic regression, patients, Cohort Studies, Quality of life, Internal medicine, Neurology (clinical), progression, patient, flexion, Medicine, Humans, Aged, Cross-Sectional Studies, Dopamine Agonists, Dystonia, Female, Italy, Middle Aged, Parkinson Disease, Syndrome, Medicine (all), business.industry, pisa syndrome, parkinson's disease, Confidence interval, pisa syndrome, parkinson's disease, Physical therapy, Pisa syndrome, Parkinson disease, patients, assessment, Settore MED/26 - Neurologia, medicine.symptom, business, Complication, Cohort study, medicine.drug
Abstract

Objective: To estimate the prevalence of Pisa syndrome (PS) in patients with Parkinson disease (PD) and to assess the association between PS and demographic and clinical variables. Methods: In this multicenter cross-sectional study, consecutive outpatients with PD attending 21 movement disorders Italian tertiary centers were enrolled and underwent standardized clinical evaluation. PS was defined as trunk lateral deviation ≥10°. Patients with PD were compared according to the presence of PS for several demographic and clinical variables. Results: Among 1,631 enrolled patients with PD, PS was detected in 143 patients (8.8%, 95% confidence interval 7.4%–10.3%). Patients with PS were older, had lower body mass index, longer disease duration, higher disease stages, and poorer quality of life. Falls were more frequent in the PS group as well as occurrence of “veering gait” (i.e., the progressive deviation toward one side when patient walked forward and backward with eyes closed). Patients with PS received higher daily levodopa equivalent daily dose and were more likely to be treated with combination of levodopa and dopamine agonists. Osteoporosis and arthrosis were significantly the most frequent associated medical conditions in patients with PS. Multiple explanatory variable logistic regression models confirmed the association of PS with the following variables: Hoehn and Yahr stage, ongoing combined treatment with levodopa and dopamine agonist, associated medical conditions, and presence of veering gait. Conclusions: Our results suggest that PS is a relatively frequent and often disabling complication in PD, especially in the advanced disease stages. The association is dependent on a number of potentially relevant demographic and clinical variables.

4. Treatment and outcome of open dislocation of the ankle with complete talar extrusion: a case report.

Author

Breccia M, Peruzzi M, Cerbarano L, and Galli M

Subjects
Adolescent, Ankle Injuries diagnosis, Follow-Up Studies, Fracture Healing, Fractures, Open diagnosis, Humans, Male, Talus surgery, Ankle Injuries surgery, Fracture Fixation methods, Fractures, Open surgery, Talus injuries
Abstract

Background: Open total talar extrusion is a severe, disabling ankle injuries. The most appropriate treatment (reimplantation versus talar body removal and tibiocalcaneal arthrodesis) is still a controversial challenge; outcomes and fearful potential complications are not predictable., Objective: To report the case of an open ankle dislocation with talar extrusion, focusing on treatment modality and outcomes., Method: Immediate reduction, surgical debridement and external fixation were performed under antibiotic coverage. Wound closure was achieved with accurate debridement, postoperative strict clinical surveillance and meticulous handling of medications. The patient maintained external fixator for three weeks, then kept non-weight bearing with a cast for an additional four weeks., Results: The patient's wound healed with no complications. Full weight-bearing was gained at 12 weeks postoperation. At 18 months postoperatively, the patient did not develop any infection or a vascular necrosis, which are the major complications associated to talar extrusion., Conclusions: Good treatment procedure for a such severe open trauma, based on accurate debridement, wound care and stable temporary immobilization with external fixation allow reduction of infection risk and made preservation of extruded talus a successful option to preserve function and normal hindfoot anatomy at first instance. Talectomy should be considered as a salvage procedure., (Copyright © 2014 Elsevier Ltd. All rights reserved.)

Published
2014
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results